News|Articles|February 1, 1999

Reportable Values for Out-of-Specification Test Results

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Doctor diagnosing patient’s health on asthma, lung disease, COVID-19 or bone cancer illness with radiological chest x-ray film for medical healthcare hospital service | Image credit: © Chinnapong - © Chinnapong - stock.adobe.com

China Clears Mepolizumab for COPD

ByFeliza Mirasol

January 5th 2026

silicon dioxide, also known as silica, is silicon oxide. Anti-caking agent, antifoam, viscosity controller, desiccant, beverage clarifier and medicine or vitamin excipient | Image Credit: ©RHJ -stock.adobe.com

Multi-Compendial Compliance for Pharmaceutical Excipients–Part 2: A Detailed Assessment for Specification Equivalence

ByJ. Mark Wiggins,Joseph A. Albanese,Gail Reed,Yelena Ionova

January 5th 2026

Dividing cancer cells - 3D illustration | Image Credit: ©peterschreiber.media - stock.adobe.com

A Year of Advancements in the Treatment of Cancer

BySusan Haigney

December 29th 2025

Quality Control Check: Scientist Using Digital Tablet Computer and wearing Protective Suit walks through Manufacturing Laboratory. Product Manufacturing: Pharmaceutics, Semiconductors | Image Credit: ©Gorodenkoff -stock.adobe.com

Missteps in GMP Facilities and Equipment Maintenance

BySusan Haigney

December 26th 2025

Women, scientist and discussion with tablet by glass, reading and review with results at pharma company. People, mentor and feedback with notes, application and medical research for mpox vaccine | Image Credit: ©peopleimages.com -stock.adobe.com

Onshoring Requires a Plan for Training

BySusan Haigney

December 25th 2025

Reportable Values for Out-of-Specification Test Results

Newsletter

Related Content

China Clears Mepolizumab for COPD

Multi-Compendial Compliance for Pharmaceutical Excipients–Part 2: A Detailed Assessment for Specification Equivalence

A Year of Advancements in the Treatment of Cancer

Missteps in GMP Facilities and Equipment Maintenance

Onshoring Requires a Plan for Training

Trending on Pharmaceutical Technology

Building the Foundations for Proactive Drug Safety in 2026

Gene Therapy, Rare Diseases, and Transfer RNA

Personalized Medicine vs. Precision Medicine

The Benefits of an Immune-Directed ADC Strategy

Why Data, Trust, and Skills Are the Foundations of AI-Driven Pharmacoviginlance